RecruitingNot ApplicableNCT03476213

Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming

Reduction of Awareness and Dreaming During Neurosurgical Procedures Using Target- Controlled Infusion, Comparison With Manual Total Intravenous Anesthesia TIVA.


Sponsor

University Hospital Hradec Kralove

Enrollment

80 participants

Start Date

Mar 16, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

This study compares manual total intravenous anesthesia (TIVA) and target-controll infusion (TCI) in reduction of awareness and dreaming, and the haemodynamical stability during operation. Half of patients will be anesthetized using manual TIVA and other half using TCI.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Glasgow Coma scale 15
  • ASA Physical Status Classification System I - III
  • planed surgery for brain tumor to 5 hours
  • postoperative awakening

Exclusion Criteria6

  • NYHA III, IV
  • abuse of stimulating drugs, grass, alcohol dependence
  • BMI over 40 in females and over 35 in men
  • propofol alergie
  • awake operations
  • postoperative arteficial ventilation

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREGroup TCI

Induction and anesthesia will be done by using Gepth model for sufentanil and Schnider effect model for propofol. Anesthetics will be aplicated using infusion pump Agilia (Fresenius Kabi). Another titration will be according to target value of entropy between 40 and 60 and surgical pleth index below 35.

PROCEDUREGroup TIVA

Induction of anesthesia will be done by titrating of propofol to the dose of 1.2 mg/kg and sufentanil 5-10 ug according to body weight, maintaining of anesthesia using continuous infusion of propofol 5 mg/ kg/hour and sufentanil 35 ug/hour to reach the target value of entropy between 40 and 60 and surgical pleth index below 35.


Locations(1)

University Hospital Hradec Kralove

Hradec Králové, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03476213


Related Trials